Senior insider sale
Chief Business Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$592.5K
20K shares
What this filing means
MEYER ANDREW HOLLMAN plans to sell 20K shares of JANUX THERAPEUTICS, INC. valued at approximately $592.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/14/2025ACC: 0001950047-25-008864
Officer· Chief Business Officer
Since Jun 2021
20K
Shares to sell
$592.5K
Approx. market value
3.33K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
11/14/2025
3.33KTotal acquired3.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/14/2025 | Exercise of Stock Options Cash | 3.33K | — |
| Total | 3.33K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.66K
Market value
$501.0K
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.33K
Market value
$91.5K
11/14/2025
Total
Units
20K
Value
$592.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/28/2025 | 16.66K | $501.0K | — | Completed |
| Planned — Approximate Date | ||||
11/14/2025 | 3.33K | $91.5K | NASDAQ | Planned |
| Total | 20K | $592.5K | ||